Related Experiment Video
Updated: Sep 23, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Reducing distress during vaccine injections: 2026 clinical practice guideline update
Anna Taddio1, Vibhuti Shah2, C Meghan McMurtry2
1Leslie Dan Faculty of Pharmacy (Taddio), University of Toronto; The Hospital for Sick Children (Taddio); Department of Pediatrics (Shah), Mount Sinai Hospital, and Department of Paediatrics and Institute of Health Policy, Management and Evaluation (Shah), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; Department of Psychology (McMurtry), University of Guelph, Guelph, Ont.; Pediatric Chronic Pain Program (McMurtry), McMaster Children's Hospital; Department of Anesthesia (McMurtry), McMaster University, Hamilton, Ont.; Children's Health Research Institute (McMurtry); Department of Paediatrics (McMurtry), Schulich School of Medicine & Dentistry, Western University, London, Ont.; Department of Emergency Medicine (Lang), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Faculty of Medicine (MacDonald), Dalhousie University, Halifax, NS; Section of Allergy (Abrams), Department of Pediatrics, University of Manitoba, Winnipeg, Man.; National Advisory Committee on Immunization (Abrams, Jensen), Public Health Agency of Canada, Ottawa, Ont.; Child Life Services (Alexander), The Hospital for Sick Children, Toronto, Ont.; Bucci-Hepworth Health Services Inc. (Bucci), Pincourt, Que.; Department of Pediatrics (Comeau), Dalhousie University; Infection Prevention and Control (Comeau), IWK Health Centre, Halifax, NS; Ontario Ministry of Health (Cortes), Toronto, Ont.; British Columbia Centre for Disease Control (Cranch), Vancouver, BC; patient partner (Gallinger, Girouard), Ont.; Foundation in Travel Medicine (Glasgow) (Golightly), GHTI, Calgary, Alta.; MAL-Health Care (Guenther), First Nations Health Authority, BC; Canadian Center for Vaccinology (Halperin), and Departments of Pediatrics, and Microbiology and Immunology (Halperin), Dalhousie University, Halifax, NS; Guideline Development and Research (Howitt), Registered Nurses' Association of Ontario, Toronto, Ont.; Mount Sinai Academic Family Health Team (Kolker); Department of Family and Community Medicine (Kolker), University of Toronto, Toronto, Ont.; First Nations Health Authority (Kryschuk), BC; St. Michael's Hospital (Minhas), Unity Health Toronto; Division of Developmental Pediatrics (Minhas), Temerty Faculty of Medicine, University of Toronto, Toronto, Ont.; Department of Psychology (Noel), University of Calgary, Calgary, Alta.; Department of Psychology (Pillai Riddell), York University; Women's College Hospital (Probst), Toronto, Ont.; Department of Paediatrics, Physiology and Pharmacology, and Medicine (Rieder), Schulich Medicine & Dentistry, University of Western Ontario, London, Ont.; Faculty of Medicine (Ross), University of British Columbia; British Columbia Centre for Disease Control (Siamaki), Vancouver, BC; EM Uleryk Consulting (Uleryk), Mississauga, Ont. anna.taddio@utoronto.ca.
Background:
Distress (pain, fear) is the most common adverse reaction associated with vaccination. This 2026 guideline updates the 2015 Help ELiminate Pain in Kids & Adults (HELPinKids&Adults) Collaborative recommendations for reducing vaccination-related distress.
Methods:
We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to select the clinical questions and critical and important outcomes, and to determine the certainty of evidence and strength of the recommendations. We aligned guideline processes and reporting with the Appraisal of Guidelines for Research and Evaluation II tool. The intended audience includes clinicians and organizations that deliver vaccinations, and vaccine recipients and their support persons. Guideline panel members representing different knowledge user groups, including vaccine recipients and support persons, voted on clinical questions and outcomes. We categorized interventions into 5 domains of distress management, the 5Ps: process (education and implementation), procedural (injection techniques), physical (body position and activity), pharmacologic (medication), and psychological (thoughts and behaviour). Five systematic reviews combined evidence from randomized and quasi-randomized controlled trials identified using database (up to Jan. 31, 2025) and hand searching, supplemented by contacting experts. Evidence summaries were presented at a guideline meeting, and voting panel members drafted recommendations using the GRADE evidence-to-decision framework, considering certainty of the evidence, magnitude of effect, and contextual factors. We applied the Guidelines International Network principles to manage competing interests.
Recommendations:
In the 5Ps framework, process-related interventions apply to all user groups. Procedural recommendations are directed at clinicians and organizations responsible for delivering vaccinations. Physical, pharmacologic, and psychological recommendations are targeted at vaccine recipients and support persons and incorporate choice. We developed 16 recommendations across the 5Ps framework, directed to different user groups. Of these, 7 are strong recommendations in favour of interventions (e.g., multicomponent process interventions, oral nutritive and non-nutritive interventions for infants), primarily supported by moderate- to high-certainty evidence. The remaining 9 are conditional recommendations based on low to very low certainty of evidence: 4 in favour of specific interventions (e.g., reducing fear cues) and 5 advising against other interventions (e.g., video or movie distraction in infants).
Interpretation:
This guideline presents evidence-based strategies to manage vaccination-related distress. Implementing recommendations can improve the quality of vaccine delivery and promote person-centred care by aligning interventions with vaccine recipient and support person preferences.
Related Concept Videos
Vaccinations
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...